Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension

European Heart Journal

Volumn 26, Issue 9, 2005, Pages 921-927

  Sciacqua, Angela ^a   Scozzafava, Angela ^a   Pujia, Arturo ^a   Maio, Raffaele ^a   Borrello, Francesco ^a   Andreozzi, Francesco ^a   Vatrano, Marco ^a   Cassano, Susanna ^a   Perticone, Maria ^a   Sesti, Giorgio ^a   Perticone, Francesco ^a,b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Policlinico Mater Domini   (Italy)

Author keywords

Atherosclerosis; Cardiac hypertrophy; Endothelium; Hypertension; Prognosis

Indexed keywords

ACETYLCHOLINE;

ADULT; ARTICLE; BODY SURFACE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FATALITY; FEMALE; FOLLOW UP; FOREARM BLOOD FLOW; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE REVASCULARIZATION; HUMAN; LERICHE SYNDROME; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STATISTICAL ANALYSIS; STROKE; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; DISEASE-FREE SURVIVAL; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 21044453406     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi112     Document Type: Article

References (36)

1. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
2. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton, FL: CRC Press; 1990.
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1998;334:1349-1357.
4. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium- dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-27.
5. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessel in hypercholesterolemic humans. J Clin Invest 1990;86: 228-234.
6. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent coronary arterial vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510-2516.
7. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilation function. Circulation 1995;92:1094-1100.
8. Quyyumj AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998; 105:325-395.
9. Chambers JC, Ueland PM, Wright M, Dore CJ, Refsum H, Kooner JS. Investigation of relationship between reduced, oxidized, and protein-bound homocysteine and vascular endothelial function in healthy human subjects. Circ Res 2001;89:187-192.
10. Lewis TV, Dart AM, Chin-Dusting JPF. Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL-cholesterol. J Am Coll Cardiol 1999;33:805-812.
11. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101:948-954.
12. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-1906.
13. Heitzer T, Schlinzig T, Krohn H, Meinertz T, Munzel T. Endothelial dysfuction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673-2678.
14. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KR, Quyyumi AA. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653-658.
15. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G. Prognostic significance of endothelial dysfuction in hypertensive patients. Circulation 2001;104:191-196.
16. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
17. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-352.
18. Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED. Hypertension and sudden death: increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984;77:18-22.
19. Koyanagi S, Eastham CL, Harrison DG, Marcus ML. Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy. Circ Res 1982;50:55-62.
20. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35:580-586.
21. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Reboldi G, Porcellani C. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97:48-54.
22. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long term antihypertensive treatment. J Hypertens. 1995; 13:1091-1095.
23. Perticone F, Maio R, Ceravolo R, Cosco C, Cloro C, Mattioli PL. Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patient. Circulation 1999;99:1991-1996.
24. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. JAMA 2003;289:2560-2572.
25. Perticone F, Maio R, Cosco C, Ceravolo R, Iacopino S, Chello M, Mastroroberto P, Tramontano D, Mattioli PL. Hypertensive left ventricular remodeling and ACE-gene polymorphism. Cardiovasc Res 1999; 43:192-199.
26. Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantification in M-mode echocardiography: results of survey of echocardiographic measurements. Circulation 1978;58:1072-1080.
27. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
28. Greenland S, Rothman KJ. (eds) In: Modern Epidemiology. Philadelphia: Lippincott Raven; 1998. p329-342.
29. Zhang J, Quan H, Ng J, Stepanavage ME. Some statistical methods for multiple endpoints in clinical trials. Contrat Clin Trials 1997; 18:204-221.
30. Lorell BH, Carabello BA. Left ventricular hypertrophy. Pathogenesis, detection, and prognosis. Circulation 2000;102:470-479.
31. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998;32:1454-1459.
32. Okin PM, Roman MJ, Devereux RB, Kligfield P. Association of carotid atherosclerosis with electrocardiographic myocardial ischemia and left ventricular hypertrophy. Hypertension 1996;28:3-7.
33. Khattar RS, Senior R, Swales JD, Lahiri A. Value of ambulatory intra-arterial blood pressure monitoring in the long-term prediction of left ventricular hypertrophy and carotid atherosclerosis in essential hypertension. J Hum Hypertens 1999;13:111-116.
34. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. A marker of atherosclerotic risk. Arteriosder Thromb Vasc Biol 2003;23:168-175.
35. Modena M, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002;40:505-510.
36. Hamasaki S, Suwaidi JA, Higano ST, Miyauchi K, Holmes DR Jr, Lerman A. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 2000;35:1654-1660.